Cargando…
Characteristics of US Patients and Prescribers Using Hydroxychloroquine During the COVID-19 Pandemic
Autores principales: | Rome, Benjamin N., Avorn, Jerry, Kesselheim, Aaron S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475861/ https://www.ncbi.nlm.nih.gov/pubmed/34561824 http://dx.doi.org/10.1007/s11606-021-07144-2 |
Ejemplares similares
-
Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing
por: Harrigan, James J., et al.
Publicado: (2020) -
US public investment in development of mRNA covid-19 vaccines: retrospective cohort study
por: Lalani, Hussain S, et al.
Publicado: (2023) -
Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in patients with rheumatic diseases
por: Pham, Khanh, et al.
Publicado: (2021) -
Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020
por: Moneer, Osman, et al.
Publicado: (2021) -
Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
por: Feldman, Daniel, et al.
Publicado: (2022)